We found a similar proportion of FGF14 expansions in both MSA-C and MSA-P, highlighting the importance of genetic testing in both these presentations when a clinical suspicion arises, irrespective of the predominant MSA clinical subtype. The gene discussed is FGF14; the disease is multiple system atrophy, cerebellar type.